Venous thromboembolism and atherosclerosis: Common denominators or different diseases?

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 9, 2006, Pages 1886-1890

  Agnelli, G ^a   Becattini, C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CALCIUM; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW MOLECULAR WEIGHT HEPARIN;

ARTERY THROMBOSIS; ATHEROSCLEROSIS; BLEEDING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY; CORRELATION ANALYSIS; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; METABOLIC SYNDROME X; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE; TISSUE DISTRIBUTION; VENOUS THROMBOEMBOLISM;

ATHEROSCLEROSIS; HUMANS; METABOLIC SYNDROME X; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33747167000     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02138.x     Document Type: Note

References (20)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50.
2. Ageno W, Prandoni P, Romualdi E, Shirarduzzi A, Dentali F, Pesavento R, Crowther M, Venco A. The metabolic syndrome and the risk of venous thrombosis. A case control study. J Thromb Haemost 2006; 4: 1914-8.
3. Eliasson A, Bergqvist D, Bjorck M, Acosta S, Sternby NH, Ogren M. Prevalence and risk of venous thrombembolism in patients with verified arterial thrombosis. A population study based on 23 796 consecutive autopsies. J Thromb Haemost 2006; 4: 1897-1902.
4. Squizzato A, Romualdi E, Ageno W. Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. J Thromb Haemost 2006; 4: 1925-7.
5. Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, Rosamond WD, Cushman M. Prospective study of subclinical atherosclerosis and venous thromboembolism. J Thromb Haemost 2006; 4: 1909-13.
6. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, Reich LM, Rosendaal FR, Cushman M. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006; 4: 1903-8.
7. Prandoni P, Ghiraduzzi A, Prins MH, Pergo V, Davidson BL, Sorensen H, Pesavento R, Iotti M, Casiglia E, Iliceto S, Pagnan A, Lensing AWA. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006; 4: 1891-6.
8. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity. Risk factors for VTE among middle-aged men: 'The study of men born in 1913'. Arch Intern Med 1999; 159: 1886-90.
9. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-5.
10. Deguchi H, Pecheniuk N, Elias D, Averell P, Griffin J. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005; 112: 893-9.
11. Tsai A, Cushman M, Rosamond W, Heckbert S, Polak JF, Folsom AR. Cardiovascular risk factors and VTE incidence. Arch Intern Med 2002; 162: 1182-9.
12. Marcucci R, Liotta AA, Cellai AP, Rogolino A, Gori AM, Giusti B, Poli D, Fedi S, Abbate R, Prisco D. Increased levels of lipoprotein (a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 2003; 115: 601-5.
13. Libertiny G, Hands L. Deep venous thrombosis in peripheral vascular disease. Br J Surg 1999; 86: 907-10.
14. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, Prins MH, Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 1435-41.
15. Hong C, Zhu F, Du D, Pilgram TK, Sicard G, Bae K. Coronary artery calcification and risk factors for atherosclerosis in patients with VTE. Atherosclerosis 2005; 183: 169-74.
16. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, Poggio R, Imberti D, Ageno W, Pogliani E, Porro F, Casazza F. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005; 26: 77-83.
17. Schulman S, Lindmarker P, Holmstrom M, Larfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Post-thrombotic syndrome, recurrence and death 10 years after the first episode of venous thromboembolism treated with warfarin for six weeks or six months. J Thromb Haemost 2006; 4: 734-42.
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308: 235-46.
19. The ESPS 2 Group. European Stroke Prevention Study 2. Efficacy and safety data. Secondary endpoints. J Neurol Sci 1997; 151: S27-S37.
20. Ray JG, Mamdani M, Tsujuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-10.